Be a part of a movement to support long-term brain health

As seen on

Dear Friends, Supporters, and Future Partners,

My name is Avi Palatnik, CEO and Co-Founder of TAHIRO. Our journey began not in a lab, but with a deeply personal conversation.

Years ago, my father was diagnosed with Alzheimer's—a disease that also affected my grandfather. This personal experience ignited a passion in me to explore cognitive health. What started as a family conversation has evolved into a mission to revolutionize brain health.

Together with my wife, Maya, a former attorney, and close friends who decided to join us and invest in our journey, we left our careers and immersed ourselves in the world of nutritional neuroscience in the U.S. It was there that I discovered I also carry the genetic predisposition to Alzheimer's. Instead of succumbing to fear, I found purpose.

Guided by the insight and vision of my father-in-law, Sasson Amit—a psychotherapist deeply passionate about the human brain—we gathered a team of leading neurobiologists and neuroscientists, including Prof. Oded Shoseyov and Dr. Ronit Shaltiel-Karyo, to develop Brain Protect™ —a formulation designed to help proactively protect against cognitive decline.

Our work is backed by cutting-edge science. Our breakthrough combines clinically studied, neuroprotective compounds with an advanced nano-absorption delivery system to enhance bioavailability and effectiveness.

After years of rigorous research and preclinical trials in France, we have observed promising results: evidence suggesting that Brain Protect may help prevent and delay Alzheimer's-like symptoms in animal models.

In the past century, global life expectancy has more than doubled—from just 36 years in 1925 to 73.3 years today. While we've made remarkable strides in treating physical health, our brains often remain untreated. This oversight is particularly concerning given that research indicates cognitive degeneration can begin 20 to 30 years before any symptoms appear.

That’s why prevention must begin now—and TAHIRO is leading that charge.

With patents pending in Europe, India, and the U.S., we're on the brink of introducing Brain Protect™ by TAHIRO to the world. But we can't do it alone.

Today, I invite you to join us on this transformative journey. Your investment doesn’t just support a product—it supports a movement to shift how we protect our most vital asset: the human brain.

Thank you for believing in a future where cognitive health is within our control.

With gratitude,

Avi Palatnik CEO & Co-Founder, TAHIRO

RSVP Today

RSVP below to receive exclusive updates for when our equity raise goes live. By signing up, you’ll be among the first to access our investment opportunity and help fuel the next evolution in cognitive health.

FAQs

What is a Testing the Waters campaign?

At any time before the filing of the Form C offering statement, an issuer, subject to specified conditions, is permitted to communicate orally or in writing to determine whether there is any interest in a contemplated offering. These are commonly referred to as “testing the waters” communications and are governed by the requirements of Rule 206 under Regulation Crowdfunding. “Testing the waters” communications are subject to the antifraud provisions of the federal securities laws.

What is Regulation Crowdfunding?

Regulation CF allows investors to invest in startups and early-growth companies. This is different from helping a company raise money on Kickstarter; with Regulation CF Offerings, you aren’t buying products or merchandise - you are buying a piece of a company and helping it grow.

What do I need to know about early-stage investing? Are these investments risky?

Sample answer goeThere will always be some risk involved when investing in a startup or small business. And the earlier you get in the more risk that is usually present. If a young company goes out of business, your ownership interest could lose all value. You may have limited voting power to direct the company due to dilution over time. You may also have to wait about five to seven years (if ever) for an exit via acquisition, IPO, etc. Because early-stage companies are still in the process of perfecting their products, services, and business model, nothing is guaranteed. That’s why startups should only be part of a more balanced, overall investment portfolio.s here.

How can I learn more about a company's offering?

Tahiro is conducting a Testing the Waters campaign under Reg CF. You can provide your email address to receive a notification if the company decides to proceed with conducting a Reg CF capital raise.

What relationship does the company have with DealMaker Securities?

Once an offering ends, the company may continue its relationship with DealMaker Securities for additional offerings in the future. DealMaker Securities’ affiliates may also provide ongoing services to the company. There is no guarantee any services will continue after the offering ends.

Disclaimers

Equity crowdfunding investments in private placements, and start-up investments in particular, involve a high degree of risk. Those who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investment through equity crowdfunding are often in earlier stages of development, and their business models, products, and services may not yet be fully developed or operational. There is no guarantee that the stated valuation or terms are accurate or in agreement with the market or industry standards. Investors may receive illiquid and/or restricted stock that may be subject to holding periods or liquidity concerns.

[DealMaker Securities LLC or relevant intermediary info, if applicable]

This website contains forward-looking statements based on management's beliefs, assumptions, and information available at the time. Such statements are subject to risks, uncertainties, and changes in circumstances. Investors should not rely unduly on these forward-looking statements, as actual results may vary significantly.